• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Podiatric care for diabetic patients is associated with reduced risk of major amputation and death

byRhianna DavisandAlex Chan
May 23, 2024
in Chronic Disease, Endocrinology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. For diabetic patients undergoing hemodialysis, receiving foot and ankle care from a podiatrist within 3 months of a new diabetic foot ulcer diagnosis was associated with a reduced risk of major amputation and death.

Evidence Rating Level: 2 (Good)

Study Rundown: Diabetic foot ulcers (DFUs) are a significant complication of diabetes, contributing to 80% of lower extremity amputations, as well as diminished quality of life and greater mortality risk. About 10-32% of patients undergoing hemodialysis also suffer from active DFUs. Previous studies suggest that the onset of hemodialysis increases the risk of developing DFUs among those with diabetes. In this retrospective cohort study, researchers aimed to determine whether receiving foot and ankle care from a podiatrist has an impact on the risk of major amputation or death for those who develop a diabetic foot ulcer while undergoing hemodialysis. In this retrospective cohort study of 14,935 participants with both diabetes and renal failure, 18.4% received podiatry care within 3 months of a new DFU diagnosis. Those who were followed by a podiatrist had a reduced risk of major amputation or death, compared to those who did not receive podiatry care. Overall, this study suggests that patients with renal failure who are at risk for DFUs may benefit from podiatry care to reduce the risk of diabetes-related amputations and mortality. 

Click to read the full study in JAMA Network Open

In-Depth [retrospective cohort study]: 14,935 adult patients with diabetes and renal failure undergoing hemodialysis were included in this retrospective cohort study, using data from the United States Renal Data System. All participants were Medicare beneficiaries. The index date was 2017, which was the time of the first DFU diagnosis. Participants were excluded from this study if they had a prior DFU in 2016, a history of major amputation, or a prior renal transplant. The remaining participants, mean (SD) age, 59.3 (12.7) years, were 55.4% male, 2.7% Asian, 35.0% Black/ African American, 17.7% Hispanic, and 58.5% White. Overall morbidity and mortality were high for this population, with 28.3% of participants undergoing a major amputation and a mortality rate of 44.6%. 

The main exposure of this study was foot and ankle care by a podiatrist, provided during the 3 months leading up to diagnosis of a DFU. 2736 of the participants received podiatry care, while 12,199 did not. Those receiving care from a podiatrist were more likely to be male, older, and have a greater burden of comorbidities  74% of those without podiatry care experienced major amputation and/or death, while these outcomes occurred for 70% of those with podiatry care. Podiatry care was associated with an 11% reduced risk of death or amputation (hazard ratio [HR], 0.89 95% CI, 0.84-0.93) compared to those without this care, determined via multivariate regression analysis. Overall, this study demonstrates that patients receiving dialysis who are receiving foot and ankle care from a podiatrist have a reduced risk of lower limb amputations and death. A limitation of this study is that the frequency of podiatry care was unknown, and it was also unknown whether participants were receiving foot and ankle care from other sources, such as their primary care providers. As well, the follow-up period of this study was relatively short, which limits the ability to draw more long-term conclusions. Overall, this study demonstrates that among diabetic patients undergoing hemodialysis, receiving foot and ankle care from a podiatrist within 3 months of a new DFU diagnosis is associated with a reduced risk of major amputation and death. 

RELATED REPORTS

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

2 Minute Medicine Rewind June 29, 2026

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: diabetesdiabetic foot ulcerinfectious diseasesmultidisciplinary carepodiatry
Previous Post

Lixisenatide as a treatment for early Parkinson’s disease progression

Next Post

Chest radiograph deep-learning model for cardiac event risk estimation

RelatedReports

Cost-related medication nonadherence associated with increased ED utilization
Pharma

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

July 15, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

July 9, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Chronic Disease

Telehealth yields modest improvements in diabetes outcomes 

June 22, 2026
Next Post
Significant number of wrong-patient errors in radiology reports

Chest radiograph deep-learning model for cardiac event risk estimation

Vitamin D supplementation amongst post-menopausal women did not improve functional outcomes

Osteoporosis prevalence in patients undergoing peritoneal dialysis is not correlated with vitamin D levels

#VisualAbstract: Single-Agent Trabectedin was noninferior to physician’s choice control chemotherapy in recurrent ovarian cancer

#VisualAbstract: Single-Agent Trabectedin was noninferior to physician's choice control chemotherapy in recurrent ovarian cancer

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy
  • Looksmaxxing raises body dysmorphia concerns among adolescent males
  • A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in